when was semaglutide patented patent expiration us As the patents on semaglutide, a popular diabetes and anti-obesity drug The Heavy Price of GLP-1
Description
Around 1 in 10 people carry variants in the PAM gene that can interfere with the activation of hormones, including GLP-1
Most people who stick with treatment through initial adjustment periods find that energy normalizes or improves beyond baseline
This slow reduction allows your natural GLP-1 production to wake up and take over
In the latest phase 2 trial, people with type 2 diabetes used different doses for up to 36 weeks while staying on metformin
